BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9003540)

  • 1. Anti-recombinogenic and convertible co-mutagenic effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted pyrimidine nucleoside analogs in S. cerevisiae MP1.
    Fahrig R
    Mutat Res; 1996 Nov; 372(1):133-9. PubMed ID: 9003540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bile acids on the mutagenicity and recombinogenicity of triethylene melamine in yeast strains MP1 and D61.M.
    Fahrig R
    Arch Toxicol; 1987; 60(1-3):192-7. PubMed ID: 3304208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-mutagenic agents are also co-recombinogenic and can be converted into co-mutagens.
    Fahrig R
    Mutat Res; 1996 Feb; 350(1):59-67. PubMed ID: 8657198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxic properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
    Oshiro Y; Piper CE; Soelter SG; Balwierz PS; Garriott ML
    Fundam Appl Toxicol; 1992 May; 18(4):491-8. PubMed ID: 1526360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive resistance of Saccharomyces cerevisiae to chronic treatment with genotoxic and nongenotoxic carcinogens.
    Fahrig R; Fahrig B
    J Environ Pathol Toxicol Oncol; 1999; 18(2):103-8. PubMed ID: 15281221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity and recombinogenicity of daunomycin in Saccharomyces cerevisiae.
    Hannan MA; Nasim A
    Cancer Lett; 1978 Dec; 5(6):319-24. PubMed ID: 365321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that induction and suppression of mutations and recombinations by chemical mutagens in S. cerevisiae during mitosis are jointly correlated.
    Fahrig R
    Mol Gen Genet; 1979 Jan; 168(2):125-39. PubMed ID: 109736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mutagenic and recombinogenic effects of some adenine analogues in Saccharomyces cerevisiae D7.
    Sorenson WG; Simpson JP; Ong TM
    Mutat Res; 1981 Jun; 82(1):95-100. PubMed ID: 7022174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene].
    Pavlov IuI; Khromov-Borisov NN
    Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diaminotoluenes induce intrachromosomal recombination and free radicals in Saccharomyces cerevisiae.
    Brennan RJ; Schiestl RH
    Mutat Res; 1997 Nov; 381(2):251-8. PubMed ID: 9434881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction or suppression of SV40 amplification by genotoxic carcinogens, non-genotoxic carcinogens or tumor promoters.
    Fahrig R; Steinkamp-Zucht A
    Mutat Res; 1996 Sep; 356(2):217-24. PubMed ID: 8841488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimutagenic effects of tumor promoters--co-mutagenic effects of co-carcinogens.
    Fahrig R
    Basic Life Sci; 1990; 52():385-8. PubMed ID: 2183777
    [No Abstract]   [Full Text] [Related]  

  • 13. Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae.
    Sengstag C; Weibel B; Fasullo M
    Cancer Res; 1996 Dec; 56(23):5457-65. PubMed ID: 8968101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the mutagenic, recombinogenic and carcinogenic potential of fipronil insecticide in somatic cells of Drosophila melanogaster.
    de Morais CR; Bonetti AM; Carvalho SM; de Rezende AAA; Araujo GR; Spanó MA
    Chemosphere; 2016 Dec; 165():342-351. PubMed ID: 27664524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenic and antimutagenic effects of 5-substituted 2'-deoxyuridines depending on the nature of the 5-substituent.
    Marquardt H; Westendorf J; Schaefer A; Boldt J; De Clercq E; Marquardt H
    Arzneimittelforschung; 1988 Dec; 38(12):1820-4. PubMed ID: 3072958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive resistance of Saccharomyces cerevisiae to chronic treatment with mutagens being due to a dominant mutation.
    Fahrig R; Kaspers I
    Mutat Res; 1990 Feb; 228(2):141-8. PubMed ID: 2105460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxic effect of alkaloids.
    Henriques JA; Moreno PR; Von Poser GL; Querol CC; Henriques AT
    Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():71-4. PubMed ID: 1842017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleomycin-induced mutation and recombination in Saccharomyces cerevisiae.
    Moore CW
    Mutat Res; 1978 Sep; 58(1):41-9. PubMed ID: 82205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic and recombinogenic effects of the antitumor antibiotic anthramycin.
    Hannan MA; Hurley LH; Gairola C
    Cancer Res; 1978 Sep; 38(9):2795-9. PubMed ID: 354779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the mutagenicity and mutagen specificity of ethylenimine with triethylenemelamine in the ad-3 region of heterokaryon 12 of Neurospora crassa.
    de Serres FJ; Malling HV; Ong TM
    Mutat Res; 1995 May; 328(2):193-205. PubMed ID: 7739603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.